AQR Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

AQR Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-37,888	Closed	-$80K	–	2273
2020 Q3	$80K	Buy	+37,888	New	+$90K	﹤0.01%	2150
2018 Q4	–	Sell	-83,524	Closed	-$344K	–	2294
2018 Q3	$344K	Sell	83,524 -37,832	-31%	-$172K	﹤0.01%	2070
2018 Q2	$630K	Buy	121,356 +17,559	+17%	+$107K	﹤0.01%	1905
2018 Q1	$569K	Buy	103,797 +33,684	+48%	+$237K	﹤0.01%	1868
2017 Q4	$571K	Buy	70,113 +17,245	+33%	+$165K	﹤0.01%	1875
2017 Q3	$554K	Buy	+52,868	New	+$587K	﹤0.01%	1903
2015 Q3	–	Sell	-22,700	Closed	-$69K	–	2276
2015 Q2	$69K	Hold	22,700	–	–	﹤0.01%	2187
2015 Q1	$67K	Sell	22,700 -21,800	-49%	-$71.4K	﹤0.01%	2110
2014 Q4	$198K	Buy	44,500 +3,500	+9%	+$16.7K	﹤0.01%	2362
2014 Q3	$211K	Buy	41,000 +25,200	+159%	+$134K	﹤0.01%	2314
2014 Q2	$83K	Buy	+15,800	New	+$68.3K	﹤0.01%	2477

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's ENZ Position: Q4 2020 in Review

AQR Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q4 2020, closing a stake of 37,888 shares — an estimated $80K sold.

AQR Capital Management first reported a position in ENZ in Q2 2014 and held it in 11 quarters. The position peaked at $630K in Q2 2018. 84 funds tracked by Wall St. Rank hold ENZ as of Q4 2020.

AQR Capital Management reported no remaining Enzo Biochem, Inc. position as of Q4 2020 after selling out during the quarter.
AQR Capital Management sold 37,888 Enzo Biochem, Inc. shares in Q4 2020, an estimated $80K.
AQR Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 11 quarters.
AQR Capital Management's Enzo Biochem, Inc. position peaked at $630K in Q2 2018.
84 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2020.

Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.